Apoptosis (programmed cell death) is the genetically controlled ablation of cells during normal development. Apoptosis is distinct from necrosis in both the biochemical and the morphological changes that occur. In contrast to necrotic cells, apoptotic cells are characterized morphologically by compaction of the nuclear chromatin, shrinkage of the cytoplasm and production of membrane-bound apoptotic bodies.
Apoptosis Assays Market contains market size and forecasts of Apoptosis Assays in Global, including the following market information:
- Global Apoptosis Assays Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Apoptosis Assays market was valued at 3315.7 million in 2021 and is projected to reach US$ 4886.8 million by 2028, at a CAGR of 5.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Caspase Assays Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Apoptosis Assays include Merck, Thermo Fisher Scientific, Becton Dickinson, Bio-Rad Laboratories, Promega Corporation, Abcam, Bio-Techne, Sartorius and Biotium, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Apoptosis Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Apoptosis Assays Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Apoptosis Assays Market Segment Percentages, by Type, 2021 (%)
- Caspase Assays
- Annexin V and Cell Permeability Assays
- DNA Fragmentation Assays
- Mitochondrial Assays
Global Apoptosis Assays Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Apoptosis Assays Market Segment Percentages, by Application, 2021 (%)
- Drug Discovery & Development
- Clinical & Diagnostic Applications
- Basic Research
- Stem Cell Research
Global Apoptosis Assays Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Apoptosis Assays Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Apoptosis Assays revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Apoptosis Assays revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Thermo Fisher Scientific
- Becton Dickinson
- Bio-Rad Laboratories
- Promega Corporation
- Abcam
- Bio-Techne
- Sartorius
- Biotium
- Creative Bioarray
- Geno Technology
- GeneCopoeia
- Danaher
- GE Healthcare
- PerkinElmer
Industry Market Size
